Clinical trial
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
NCT01243606 is registered in ClinicalTrials.gov with Boston University Charles River Campus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
- Lead sponsor
- Boston University Charles River Campus
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2010
- Completion date
- May 31, 2017
- Enrollment
- 250 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.